In the complex world of pharmaceutical manufacturing, the precise synthesis of active pharmaceutical ingredients (APIs) hinges on the quality and availability of key intermediates. One such critical compound is 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride, identified by its CAS number 183322-17-0. This molecule serves as a fundamental building block in the synthesis of Erlotinib, a vital antineoplastic agent widely used in cancer therapy.

Erlotinib is a targeted therapy, specifically an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It has proven efficacy in treating certain types of lung cancer and pancreatic cancer. The journey from raw chemical components to a life-saving medication is intricate, with each intermediate playing a precise role. The compound with CAS 183322-17-0 is indispensable in establishing the core structure of Erlotinib, ensuring the final drug possesses the desired pharmacological activity.

For R&D scientists and procurement managers in the pharmaceutical industry, securing a reliable source for high-purity intermediates like 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride is paramount. A consistent supply chain and guaranteed quality are not just operational necessities but direct determinants of the final product's efficacy and safety. When looking to buy 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride, it is crucial to partner with experienced manufacturers who can provide comprehensive technical data and adhere to strict quality control standards. Understanding the price of 183322-17-0 will also be a key consideration for budget planning in your API manufacturing process.

As a leading pharmaceutical intermediate supplier in China, we are dedicated to supporting the global pharmaceutical industry. We ensure that our 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride, manufactured with precision and subjected to rigorous testing, meets the demanding specifications required for Erlotinib production. Our commitment as a CAS 183322-17-0 manufacturer means we offer not just the product, but also the assurance of quality and consistent availability needed for commercial drug manufacturing. Choosing a reputable supplier is an investment in the success of your pharmaceutical projects.